Interactions of MRZ 2/576 with Felbamate, Lamotrigine, Oxcarbazepine and Topiramate in the Mouse Maximal Electroshock-Induced Seizure Model
Authors:
- Jarogniew J. LuszczkiJLJarogniew J. Luszczki
- Wojciech DanyszWDWojciech Danysz
- Stanislaw J. CzuczwarSCStanislaw J. Czuczwar
- 4 February 2008
- journal article
- Published by S. Karger AG in Pharmacology
- Vol. 81 (3) , 259-265
Abstract
This study focused on the evaluation of interactions between MRZ 2/576 (8-chloro-4-hydroxy-1-oxo-1,2-dihydropyridazino(4,5-b)quinoline-5-oxide choline salt), an N-methyl-D-aspartate (NMDA) receptor antagonist acting at the NMDA receptor/glycineB site and four newer antiepileptic drugs (felbamate, lamotrigine, oxcarbazepine, and topiramate) in the mouse maximal electroshock seizure model. Results indicate that MRZ 2/576 administered intraperitoneally, 5 min before the test, exerted a clear-cut anticonvulsant effect in the maximal electroshock seizure test in mice and its ED50 value was 13.71 (11.95–15.73) mg/kg. In the subthreshold method, MRZ 2/576 (administered intraperitoneally, at a subthreshold dose of 5 mg/kg) significantly enhanced the anticonvulsant action of felbamate, oxcarbazepine and topiramate, by reducing their ED50 values from 73.0 to 53.8 mg/kg (p < 0.05) for felbamate, from 10.77 to 7.48 mg/kg (p < 0.05) for oxcarbazepine, and from 49.3 to 28.7 mg/kg (p < 0.01) for topiramate. In contrast, MRZ 2/576 (5 mg/kg, i.p.) did not significantly affect the antiseizure effects of lamotrigine in the maximal electroshock seizure test in mice. Isobolographic transformation of data revealed that MRZ 2/576 (5 mg/kg, i.p.) exerted barely additive interactions with all investigated antiepileptic drugs in the maximal electroshock seizure test. In conclusion, the isobolographic analysis revealed that MRZ 2/576 additively cooperates with newer antiepileptic drugs in terms of suppression of maximal electroshock-induced seizures in mice.Keywords
This publication has 16 references indexed in Scilit:
- Peripherally acting NMDA receptor/glycine site receptor antagonists inhibit morphine toleranceNeuropharmacology, 2005
- Isobolographic and Subthreshold Analysis of Interactions among Felbamate and Four Conventional Antiepileptic Drugs in Pentylenetetrazole‐induced Seizures in MiceEpilepsia, 2004
- Preclinical Profile of Combinations of Some Second‐generation Antiepileptic Drugs: An Isobolographic AnalysisEpilepsia, 2004
- Interactions between riluzole and conventional antiepileptic drugs – a comparison of results obtained in the subthreshold method and isobolographic analysisJournal of Neural Transmission, 2004
- The New Generation of GABA EnhancersCNS Drugs, 2001
- Epilepsy after the first drug fails: substitution or add-on?Seizure: European Journal of Epilepsy, 2000
- REVIEW Antiepileptic drugs: safety in numbers?Seizure: European Journal of Epilepsy, 2000
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure modelsEpilepsy Research, 1991
- Trimethoprim and rifampicin: in vitro activities separately and in combinationJournal of Antimicrobial Chemotherapy, 1975